As an essential nutrient and a potential toxin, iron poses an exquisite regulatory problem in biology and medicine. At the cellular level, the basic molecular framework for the regulation of iron uptake, storage, and utilization has been defined. Two cytoplasmic RNA-binding proteins, iron-regulatory protein-i (IRP-1) and IRP-2, respond to changes in cellular iron availability and coordinate the expression of mRNAs that harbor IRP-binding sites, iron-responsive elements (IREs). Nitric oxide (NO) and oxidative stress in the form of H202 also signal to IRPs and thereby influence cellular iron metabolism. The recent discovery of two IRE-regulated mRNAs encoding enzymes of the mitochondrial citric acid cycle may represent the beginnings of elucidating regulatory coupling between iron and energy metabolism. In addition to providing insights into the regulation of iron metabolism and its connections with other cellular pathways, the IRE/IRP system has emerged as a prime example for the understanding of translational regulation and mRNA stability control. Finally, IRP-1 has highlighted an unexpected role for iron sulfur clusters as posttranslational regulatory switches.
but to prevent accumulation of excess iron. Insufficient iron uptake impairs cell growth in culture, and nutritional deprivation or malabsorption in whole organisms provokes anemia. In contrast, transfusional iron overload and pathologically increased iron uptake in genetic hemochromatosis will exceed the extracellular iron binding capacity of transferrin as well as the intracellular iron storage capacity of ferritin, leading to permanent cell and tissue damage.
The expression of key proteins in the iron metabolism of vertebrate cells is controlled by intracellular iron levels. This regulation is mediated by specific mRNA-protein interactions in the cytoplasm. Particular hairpin structures, called ironresponsive elements (IREs) in the respective mRNAs, are recognized by trans-acting proteins, known as iron-regulatory proteins (IRPs) [formerly referred to as IRE-binding protein (IRE-BP), iron regulatory factor (IRF), or ferritin repressor protein (FRP)], that control the rate of mRNA translation or stability.
Two closely related IRPs (IRP-1 and IRP-2) have been identified to date. Both display IRE-binding under conditions of iron deprivation, but become posttranslationally inactivated (IRP-1) or degraded (IRP-2) when the iron supply to cells is increased. The posttranscriptional control mechanisms that result from the IRE-IRP interactions have provided a frame for our current thinking about cellular iron homeostasis and the maintenance of an adequate steady state level of "free" cellular iron at the crossroads between iron uptake, iron storage, and iron incorporation into proteins (Table 1) . Because IREs are present in various mRNAs that encode proteins functioning in either of these pathways, IRE-IRP interactions affect virtually all major aspects of iron metabolism.
IREs were first identified in the 5' untranslated regions (UTR) of ferritin H-and L-chain mRNAs (1-4) and found to mediate inhibition of ferritin mRNA translation in iron-deprived cells. However, ferritin synthesis is not repressed when cellular iron is plentiful. Under such conditions, newly made ferritin baskets assemble, increasing the iron storage capacity of the cell. The physiological significance resides in a feedback regulation whereby a chelatable "free" cytoplasmic iron pool controls the formation of its own deposition site. This notion is fully supported by the finding that inhibition of ferritin mRNA translation in vitro depends directly on the binding of IRP-1 to the ferritin H-and L-chain mRNA 5' IREs (5, 6) .
Shortly after the discovery of IREs in ferritin mRNAs, five similar motifs were identified within the 2.7 kb 3' UTR of transferrin receptor (TfR) mRNA (7) . The precise location of these IREs coincided with two regions of about 200 bases each, which are known to confer differential stability to transferrin receptor mRNA as a function of cellular iron levels (8) (9) (10) . The predicted interaction of IRP-1 with the TfR IREs was readily demonstrated in cells treated with an iron chelator and correlates perfectly with the induction of TfR mRNA and protein after iron deprivation (11, 12) . Likewise, iron addition inhibits the IRE-binding activity of IRP-1 within 2 hr and leads to the degradation of TfR mRNA. Based on numerous deletions and mutations in the regulatory region, bound IRP-1 appeared to protect TfR mRNA from rapid degradation. Hence, iron deficiency is compensated by increased receptor levels, permitting cells to absorb more iron by endocytosis of transferrin. Apparently, like iron storage, iron uptake is adjusted by a feedback control loop in which an intracellular "free" iron pool controls its own size.
A more extended regulatory network operating through IRPs appears to connect the synthesis of protoporphyrin IX in erythroid cells and of certain mitochondrial iron sulfur proAbbreviations: IRP, iron-regulatory protein; IRE, iron-responsive element; UTR, untranslated region; TfR, transferrin receptor; 5-ALAsynthase, 5-aminolaevulinic acid synthase.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (17) (18) (19) (20) (21) . The IRE in 5-ALA-synthase mRNA represents a regulatory connection between iron availability and heme synthesis for hemoglobin, which constitutes the major iron utilization pathway. The inhibitory effect of activated IRPs on the synthesis of 5-ALA-synthase, the first enzyme in heme synthesis, can be viewed as a way to reduce excessive protoporphyrin production under conditions of iron deprivation (13-15, 19, 20) . However, direct experimental evidence for this prediction is still missing. Moreover, with IREs present in mRNAs encoding citric acid cycle enzymes, a hitherto unexpected connection between iron and mitochondrial energy metabolism seems to emerge. Why this connection has evolved remains largely unknown. One possible explanation may relate to a preventive mechanism whereby cells could limit the accumulation of apoprotein subunits of Fe-S proteins, which may perturb the function of multienzymatic pathways. Another possible reason discussed further in this review may relate to the prevention of "oxidative stress." The discovery of these new IREs confirms their early evolutionary origin, which can be traced back to arthropods and mollusks (22, 23) . This corroborates previous results showing the conservation of IRE-binding activity in annelids and insects as well as vertebrates, and the lack of such activity in yeast, bacteria, or plants (5, 24, 25) . It is quite possible that the known network of IRE-regulated mRNAs may grow in the future. Transferrin mRNA has also been suggested as a possible candidate, because it contains a 5' sequence that vaguely resembles an IRE and that seems to bind a cellular protein with properties similar to IRPs in vitro (26, 27) . However, this proposed interaction was not confirmed with recombinant human IRP-1 (28).
IRP-1 and IRP-2 Binding To IREs
The IRE is highly conserved in evolution for any given gene and is remarkably similar between different genes harboring such elements, suggesting precise structural constraints in the binding to IRPs. The canonical IRE consists of a stem-loop structure with an upper double-stranded, 5-bp-long helix of variable sequence and a six-nucleotide loop with the consensus sequence 5'-CAGUGN-3'. Below the paired stem, there is invariantly a small asymmetrical bulge with an unpaired cytosine as the first nucleotide 5' of the stem (29) . In certain IREs, this bulge is best drawn with a single unpaired C nucleotide; in other IREs, the C nucleotide and two additional 5' nucleotides seem to oppose one free 3' nucleotide. The bulge may serve to adopt a specific bend in the IRE structure. Beyond the bulge, a second base paired region without evident sequence constraints appears to stabilize the IRE hairpin (Fig. 1) .
Several studies have elucidated the structure and sequence constraints within which this motif serves as a recognition site for IRP-1. Whereas wild-type IREs show a very high affinity binding to IRP-1 (Kd -10-30 pM) (30, 31) , deletion of nucleotides in the loop and the bulge region severely impair or destroy the high affinity (4, 28, 32) . Moreover, point mutants disrupting the upper helix were found to be nonfunctional, whereas complementary mutations restoring the double strandedness are tolerated (31, 33, 34) . Exchanges in the first five loop nucleotides and the bulge nucleotides usually cause a marked decrease in binding to IRP-1 (28, (31) (32) (33) . However, such mutations may dramatically affect regulation in vivo, as documented in a case of dominant familial hyperferritinemia that leads to early-onset cataract (35) . In this family, the ferritin L-chain gene carries an A2 -* G2 mutation in the IRE-loop, which lowers its affinity to IRP provoking excessive ferritin synthesis in affected individuals.
The best IRP-1-binding sequences among IREs were selected from a pool of 16,384 different IRE variants, where the six nucleotides in the loop and the free 5' C nucleotides were permutated randomly (28 (28) . Likewise, a G'C5 (but not an A1U5) pair provides a high affinity IRE (36) . Base interactions in the loop have also been observed by NMR analysis of the IRE structure (37) . The selex approach also yielded IRE mutants that selectively bind to IRP-1, but not to IRP-2 (28) , and a set of double mutations that is specific for IRP-2 was recently identified by a direct screening method (36) . Thus, the constraints for IRE (28, 36) . Considering the relatively high affinity of certain IRE mutants, hitherto unrecognized mRNAs could nevertheless be regulated through such noncanonical IREs, perhaps exclusively either by IRP-1 or by IRP-2.
Mechanism of Translational Control by IRPs
As early as 1966, iron regulation of ferritin expression was considered to involve translational control (39) . Munro and colleagues showed that the activation of ferritin synthesis in iron-treated rats is insensitive to transcription inhibitors and is associated with a shift of ferritin mRNA from translationally inactive messenger ribonucleoprotein particles to polyribosomes (40) . They suggested that a protein (perhaps a ferritin subunit) binds to the 5' UTR of ferritin mRNA and suppresses its translation in iron-deficient cells. Likewise, iron regulation of ferritin synthesis in reticulocytes of bullfrog tadpoles was shown to be translational (41, 42) . By the end of the 1980s, the regulation of ferritin translation by iron-controlled binding of IRP-1 to an IRE in the 5' UTRs of ferritin H-and L-chain mRNAs had emerged as an extensively studied example of translational regulation of a mammalian gene (1, 3-6, 29, 43-46) . The IRE is necessary for the posttranscriptional regulation of ferritin expression by iron (3, 45) and suffices to confer IRP-mediated translational control to reporter mRNAs in transfected cells (1, 3, 4) .
Plant and yeast cells lack endogenous IRP activity (5, 24, 25, 46) . Because the moderately stable hairpin of the IRE (c-7 kcal/mol) does not impede translation per se, IRE-containing mRNAs are efficiently translated in Saccharomyces cerevisiae (25) and in cell-free extracts from wheat germ (40, 42) . The translation of suitable reporter mRNAs is specifically repressed by coexpression of IRP-1 in S. cerevisiae (25) or by addition of purified IRP-1 to wheat germ extract (5, 46, 47) . At least in vitro, IRP-mediated translational repression does not require polyadenylylation of the mRNA template (6) . These findings indicate that the binding of IRP-1 [or IRP-2 (48) ] to the IRE suffices to regulate translation without requirement for additional cis-acting sequences or transacting factors. Nevertheless, adjacent non-IRE sequences may affect the function of an IRE (49, 50) , and pre-and posttranslational mechanisms in addition to IRE-mediated translational control can quantitatively contribute to the iron regulation of ferritin expression in vivo (39, (51) (52) (53) .
How does an IRE/IRP complex inhibit mRNA translation? Using cell-free translation systems and sucrose gradient analyses, this complex was shown to prevent the stable association of the small ribosomal subunit (the 43S translation preinitiation complex) with mRNA (21 (55) as well as in cell-free translation systems from rabbit reticulocytes and wheat germ (56) . As with the IRE/IRP interaction, the function of the complex is position dependent (56) and prevents the stable association of the small ribosomal subunit (21) . These results suggest that IRE/IRP complexes act as steric inhibitors of 43S preinitiation complex binding (Fig. 2) . Moreover, these results argue that this mechanism reflects a more general mode for translational control that could also explain the translational regulation of other mRNAs (57) .
Mechanisms Controlling Transferrin Receptor mRNA Stability TfR protein expression in proliferating cells was reported in the early 1980s to respond to variations in iron availability (58, 59) . After the isolation of TfR cDNAs (60) (61) (62) , it was noted that iron chelators increase and iron salts or hemin diminish TfR mRNA levels in cultured cells (63) . Surprisingly, the regulation was not primarily the result of transcriptional control as initially expected (64), but could be ascribed to sequences in the 3' UTR of the TfR mRNA (8) . Deletion of the 3' UTR yields a high, nonregulated expression of TfR in transfectant cell lines. The TfR mRNA 3' UTR is also sufficient to confer iron-dependent regulation to a chimeric transcript of HLA-A2 (9) or human growth hormone (7) . Deletion mapping of the regulatory sequences identified two necessary areas of about 200 nucleotides each, separated by some 250 nucleotides (9, 10) . These relevant regulatory sequences, but not the adjacent 3' UTR regions, display -94% sequence identity between human and rat (65) mRNAs and 89% between human and chicken TfR mRNAs (12, 66) , a conservation that exceeds that of the coding regions.
This bipartite regulatory region of TfR mRNA is more complex than that of ferritin mRNA, and both RNA-stabilizing and -destabilizing elements have been identified (Fig. 3) . Because it is rather large, its structure cannot be predicted with certainty. through pairing of two of their IREs (9) , whereas in the other model all IREs are in a hairpin conformation (7) . This second model has been directly supported by RNA probing and in vivo footprinting experiments (67, 68) . In vitro binding experiments also suggest that at least four IREs are accessible for IRP-binding (11) . However, only some 250 nucleotides, including IREs B, C, and D (Fig. 3) , are minimally required for regulation (9, 69 (69) . On the other hand, mutations or deletion of the destabilizing regions give rise to a constitutively stable mRNA (7, 9, 69) . As soon as iron inactivates IRPs, the dissociation of the IRE-IRP interaction can be observed in cells (68, 70) , which appears to expose the instability site(s). Whether or not a structural change in the mRNA precedes its degradation remains to be determined.
Specific mRNA cleavage products within the 3' regulatory region close to the previously mapped instability elements were identified in a human plasmacytoma cell line (71 (82) (83) (84) .
Alterations in IRP-1 activity occur without notable changes in the total amount of IRP-1. This total amount can also be estimated by addition of 2% 2-mercaptoethanol to cell extracts, which converts IRP-1, whether spontaneously active or not, into an active IRE-binding form (76, 77, (85) (86) (87) (88) . This observation also provided the first evidence that the change in IRP-1 activity results from an iron-induced posttranslational modification (76) . To understand the cause of this phenomenon, IRP-1 was purified to homogeneity from liver (46, 86, 89) and placenta (85) , and corresponding cDNAs were isolated (81, (89) (90) (91) (92) . The protein comprises 889 amino acids with a predicted molecular mass of close to 98 kDa, and exists as a monomer in the cytoplasm (11) . Strikingly, IRP-1 displays a marked homology with mitochondrial (93, 94) and bacterial (95, 96) aconitases, which are iron sulfur proteins that interconvert citrate and isocitrate. The significance of this observation was corroborated experimentally; the amino acid backbones of human IRP-1 and cytoplasmic beef heart aconitase were shown to be the same (97) . In the presence of ferrous iron and sulfide in vitro and in iron-replete cultured cells, IRP-1 is converted into a cytoplasmic aconitase by the insertion of a 4Fe-4S cluster liganded to three cysteine residues that occur at homologous positions in the mitochondrial and bacterial enzymes (47, 87, (97) (98) (99) (100) (101) (102) (103) . The 4Fe-4S cluster-containing IRP-1 is inactive in IRE-binding (Fig. 4) . In iron-deficient cells, however, the apoprotein form without the cluster accumulates and binds to IREs. The conversion between the two forms reflects the cellular iron-sensing mechanism that in turn controls the interaction with IRE-containing mRNAs and their fate. The mechanisms by which cellular iron regulates the removal or the insertion of the 4Fe-4S cluster into IRP-1 remain largely unknown. IRP-1 apoprotein usually accumulates slowly within "15 hr of iron deprivation, and in certain cell lines the accumulation of the IRE-binding activity is retarded but not prevented by translation inhibitors (11, 76, 101, 104, 105) . It suggests that IRP-1 apoprotein in vivo arises both from de novo synthesis and frotn the loss of the 4Fe-4S cluster from cytoplasmic aconitase. Insertion of the 4Fe-4S cluster dramatically lowers the affinity for the IRE (30) and promotes its dissociation from mRNA in cells (68, 70) . This is directly supported by mutagenesis experiments. When the critical cysteines in IRP-1 are mutated to serines, IRP-1 is unable to insert the 4Fe-4S cluster and remains constitutively active in IRE-binding both in vitro (88, 106) and in cultured cells (88, 107) . Cells that express such a protein are dysregulated in TfR and ferritin expression (108) .
By analogy with the crystal structure of mitochondrial aconitase (109, 110) , IRP-1 presumably forms a four-domain protein with a deep cleft between domains one and three and the fourth domain that is connected by a somewhat flexible hinge linker (Fig. 4) . IRE-binding appears not to be confined to a small domain, but rather to involve several regions of the protein, whose diameter roughly matches the length of the IRE stem-loop. Alkylation of or disulfide formation involving cysteine residue 437, which lines the cleft and is implicated in 4Fe-4S cluster coordination, inhibits IRE-binding (76, 88, 106) . UV crosslinking has suggested a direct contact between the IRE and amino acids 121-130 of human IRP-1 (111), which are also predicted to reside near the cleft. While these data are consistent with the results of a second UV crosslinking study (112) , the complexity of the RNA/protein interaction is illustrated by a second crosslinking site between amino acids 480 and 623 that has been reported for rabbit IRP-1 (113 IRP-2 is less abundant than IRP-1 in most cells. In gel retardation assays, the tissue distribution of IRP-2 appeared restricted with the strongest expression in intestine and brain (78, 80) . More recently, specific antibodies have detected the protein in several additional tissues (114) . The cloning of full-length cDNAs for IRP-2 from man (80, 90, 114, 115) and rat (114) has contributed to rapid new progress. Human IRP-2 is 57% identical and 79% similar to human IRP-1. IRP-2 is slightly larger with a molecular mass of 105 kDa (78) (79) (80) 114) due to the presence of a 73 amino acid insertion as compared with No aconitase activity has been found to be associated with purified or recombinant IRP-2 (79, 80) . Although IRP-2 has the equivalent cysteine residues that coordinate the Fe-S cluster in IRP-1, it remains unclear whether IRP-2 accommodates such a cluster. Unlike IRP-1, IRP-2 is physically degraded in iron-replete cells (79, 80, 104, 105) . The degradation of IRP-2 is mediated through the unique 73 amino acid domain in the protein (116) . Its deletion stabilizes IRP-2, whereas its grafting onto IRP-1 confers iron-dependent degradation to the hybrid protein. IRP-2 degradation appears to occur in the proteasome, because it is prevented by specific proteasome inhibitors (116, 117) . Interestingly, heme-induced instability has been reported previously for a rabbit IRP that disappeared with rapid kinetics after conversion to a higher molecular mass complex (118) . Since the direct, covalent binding of heme was suggested to cause the degradation of this IRP (assumed to be IRP-1) (119, 120), which was inconsistent with the posttranslational Fe-S switch mechanism, it was considered as an experimental artifact (121) . In retrospect, it seems possible that at least some of the properties described for this rabbit IRP may have been those of IRP-2.
The specific roles of IRP-2 are currently unresolved. Further experimentation including gene knock-outs in mice should provide more definitive results as to the specific roles of either protein in iron metabolism. Regulation of Iron Metabolism by Nitric Oxide (NO) and Oxidative Stress
The specificity of the control of iron uptake (TfR), storage (ferritin), and utilization (erythroid 5-ALA-synthase) for iron initially portrayed the IRE/IRP regulatory system as being confined to the maintenance of cellular iron homeostasis in response to changes in iron availability and demand. It is now clear that signals other than iron levels can regulate IRP-1 and IRP-2 and modulate cellular iron metabolism. Moreover, the regulation of two citric acid cycle enzymes by IREs further illustrates that the control of iron metabolism is interconnected with other cellular pathways.
Mitochondrial aconitase has been described as a target for the tumoricidal activity of NO released from activated macrophages (122) (123) (124) . Based on the structural similarity between mitochondrial aconitase and IRP-1 (93, 94) , the response of the IRPs to NO was investigated in murine peritoneal macrophages and macrophage cell lines (125, 126) . Stimulation of macrophages with interferon--y (IFN--y) and lipopolysaccharide (LPS) induces NO synthesis and activates IRE-binding by IRP-1 and IRP-2 (indicated by a "?" in ref. 126 ). This activation is NO dependent and accompanied by a loss of the aconitase activity of IRP-1. NO regulation of IRPs is not confined to macrophages and does not require cytokine stimulation in certain nonmacrophage cell lines. It can be elicited with NO-releasing drugs and has also been observed in the erythroid cell line K562 (126) (127) (128) , rat brain slices (129) , and the mouse fibroblast cell lines B6 and Ltk- (130, 131) . In the latter case, it was directly shown that ferritin synthesis was repressed and TfR mRNA levels were raised, demonstrating that IRP activation by NO functionally manifests itself in cultured cells (130) . In IFN-,y/LPS-stimulated macrophages, TfR mRNA levels are diminished rather than increased (125, 130) , presumably due to a cytokine-induced reduction in TfR mRNA synthesis that can be overcome by the antiinflammatory cytokines interleukins 4 Review: Hentze and Kiihn I |ERP 2l and 13 (G. Weiss, C. Bogdan, and M.W.H., unpublished results). The regulatory crosstalk between iron metabolism and NO in macrophages is further highlighted by the transcriptional regulation of the inducible NO synthase gene (NOS 2) by iron (132) . Thus, in macrophages, the regulation of iron metabolism and NO is tightly connected. Future work will have to address the role of this regulatory connection in animal models, where macrophages are exposed to the influence of multiple, partially antagonistic cytokines.
Another important biological link exists between iron metabolism and oxidative stress. This link is most directly illustrated by Fenton chemistry, which yields the highly reactive and toxic hydroxyl radical from the reaction of Fe2+ (or Cu+) with H202. Much of the damage inflicted to cells by oxidative stress is mediated by iron, as has been suggested for atherosclerotic lesions (133) and in hypoxia-reperfusion injury (134, 135) . In bacteria, oxidative stress and the regulation of iron metabolism are tightly coupled (136, 137) . In mammalian cell lines, IRP-1 establishes a direct regulatory linkage between iron metabolism and oxidative stress (138, 139) . Whereas Escherichia coli aconitase is inactivated by superoxide and peroxynitrite (140) , the cytoplasmic aconitase (IRP-1) responds strongly to H202 in living cells but not in vitro (138, 139) . This response involves the inactivation of its aconitase activity (139) and the rapid stimulation of IRE-binding in several mammalian cell lines (130, 138, 139) , leading to increased TfR mRNA levels and repressed ferritin synthesis (139) . The H202 responsiveness of IRP-1 may also explain the increase in ferritin synthesis observed after ascorbic acid addition to cultured K562 cells (141) , because the antioxidant vitamin may counteract the effects of H202 on IRP-1. H202 activates almost exclusively IRP-1 (131) , possibly because the cellular pool of preformed activatable IRP-2 is very small.
How do the small diffusible molecules NO and H202 trigger IRP activation? Both molecules activate IRP-1 by a cycloheximide-insensitive posttranslational mechanism (139), whereas IRP-2 activation by NO requires de novo protein synthesis (131) . After treatment of cells with NO or H202, the 4Fe-4S clusterdependent aconitase activity is inhibited (125, 139) . Citrate that can bind to a 3Fe-4S or a 4Fe-4S cluster of IRP-1 and prevent IRE-binding after treatment of extract with reducing agents (87) fails to inhibit IRE-binding of NO-or H202-activated IRP-1 (131, 139) , suggesting that the cluster is disassembled in NO-or H202-treated cells beyond the 3Fe-4S state and perhaps absent. However, direct proof for the conversion of IRP-1 into the apoprotein form by NO and H202 is currently still lacking.
Surprisingly, the activation of IRP-1 by NO differs significantly from H202 activation and more closely resembles the pattern of activation observed in iron-deficient cells. Iron deficiency and NO require up to 15 hr for complete activation of IRP-1 (and IRP-2) (11, 76, 131) , whereas H202 achieves maximal IRP-1 activation within '60 min (138, 139) . Furthermore, IRP-1 activation by H202 is diminished by the type I/Ila protein phosphatase inhibitor okadaic acid in B6 cells, whereas the activation by iron deficiency and NO is insensitive to this drug (131, 139 (142) . Given that PMA can induce the formation of reactive oxygen intermediates (143) and is known to activate the oxidant stress-responsive transcription factor NFKB (144) , the roles of H202, PMA, and protein kinase C in IRP-1 activation may be related.
How then does NO activate IRP-1 and IRP-2? Drapier et al. (125) found that exposure of recombinant IRP-1 to NO gas under anaerobic conditions completely inhibits its aconitase activity and partially (-20%) activates IRE-binding. In contrast, lack of inactivation of the aconitase activity of recombinant human IRP-1 by NO gas under apparently similar conditions has also been claimed (140) (134, 135, 145) .
To further dissect the translational control mechanism, it will be important to understand how RNA/protein complexes such as IRE/IRP interfere with the binding of the small ribosomal subunit. Do IRPs stabilize the secondary structure of the IRE to prevent its unwinding or does the complex impede the function of translation initiation factors (such as those binding to the cap structure) required for the subsequent binding of the 43S preinitiation complex? How does the translation initiation apparatus overcome a downstream IRE/IRP complex? This may yield interesting information on how mRNA translation can occur in an environment abounding with RNA-binding proteins. Regarding the regulation of TfR mRNA stability, the two critical future questions pertain to the identification and characterization of the nuclease(s) against which IRE/IRP complexes protect the RNA as well as the secondary and tertiary structure of the TfR mRNA substrate that this nuclease recognizes and cuts. Since it is unlikely that a complete nuclease system evolved solely for the purpose of degrading TfR mRNA, it will also be interesting to identify the substrate spectrum of this nuclease.
While the role of iron sulfur clusters in electron transfer or enzymatic reactions is well-documented, we are still just beginning to understand how iron sulfur clusters act as regulatory switches. Regarding IRP-1, two aspects must be distinguished: (i) how the presence of the cluster inhibits IRE-binding and (ii) how different cellular signals operate the switch between 4Fe-4S protein and apoprotein. The former question is intimately connected with the elucidation of the structure of IRP-1 and of the IRE/IRP-1 complex. Answering the latter question will necessitate a biochemical definition factors involved in cluster assembly and disassembly. Is cluster formation a "spontaneous" process driven by the availability of ferrous iron and sulfide or is it cofactor mediated? At what rate does the cluster come apart? Can this process be accelerated? Is the cluster a sensor of the signals that affect it or merely a respondent to processes triggered by these signals? Finding the answers to these questions will likely also impact on other regulatory systems, as additional examples of iron sulfur cluster-controlled regulatory proteins have recently begun to emerge; this group includes the prokaryotic oxidant stress response factor soxR (a DNA-binding protein) (146) , the oxygen-regulated transcription factor FNR from E. coli (147) , and a family of transcription factors that harbors so-called LIM domains (for the founding members lin-11, Isl-1, and mec-3) (148). There is also much left to be learned about the regulation of IRP-2. Is the formation of an iron sulfur cluster part of the process leading to its degradation? How does the 73 amino acid domain unique to IRP-2 mark the protein for degradation in iron-replete cells? How is degradation prevented in iron-deficient cells?
The IRE/IRP system is beginning to emerge from its confines of representing a closed circuit "housekeeping" system for iron homeostasis, as illustrated by its interconnections with the citric acid cycle or the cytokine/NO regulation in activated macrophages. Much information will have to be gathered on the roles that the two diffusible messengers, NO and H202, play in regulating IRE-containing mRNAs. IRP-1 activation by H202 decreases ferritin and increases TfR expression (139) . An increase in iron uptake and a decreased potential to store intracellular iron in ferritin should raise the level of "free" iron that can react with H202 and yield hydroxyl radicals. Thus, this regulatory loop may catalyze tissue damage rather than be protective. The pathophysiological implications of this situation, particularly in vascular disorders such as reperfusion injury where iron-derived reactive oxygen species appear to play an important role (134, 135) , will warrant further investigations. Similarly, we have to learn how tissues initiate counterbalancing protective mechanisms, as indicated by the induction of ferritin expression >12 hr after an oxidant injury (149) (150) (151) . What are the physiological benefits of H202-mediated IRP-1 activation? A rather speculative lead may be offered by the IREs that serve to repress the translation of two citric acid cycle enzymes after IRP activation in mammals and invertebrates (17, 18) . The citric acid cycle fuels the respiratory chain with reducing equivalents and thus contributes to the formation of reactive oxygen intermediates during mitochondrial ATP synthesis. Could the activation of IRP-1 by excess H202 serve as a metabolic homeostat to balance respiratory ATP synthesis and oxidative stress by exerting negative feedback on the citric acid cycle? The regulation of IRP-1 by endogenously generated reactive oxygen intermediates after pharmacological modulation of respiratory chain activity is at least consistent with this possibility (131) .
Finally, the appreciation of the role of transferrin in extracellular iron transport is in stark contrast to the lack of molecular understanding of intracellular iron transport. Neither the process by which iron leaves the endosome nor the traffic of iron between the cytoplasm and mitochondria are well-understood. 
